CJS Securities Downgrades Haemonetics (HAE) to Market Perform
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
CJS Securities downgraded Haemonetics (NYSE: HAE) from Market Outperform to Market Perform with a price target of $35 (unchanged).
Shares of Haemonetics closed at $37.23 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H.C. Wainwright Downgrades Vertex (VRTX) to Neutral
- Mizuho Securities Downgrades Teva Pharma (TEVA) to Neutral
- BofA/Merrill Lynch Downgrades Electronic Arts (EA) to Neutral
Create E-mail Alert Related CategoriesDowngrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!